We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
10 Year Est. Return
AUM
$2.17B
AUM Growth
+$131M
Cap. Flow
-$24.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
45.36%
Holding
43
New
2
Increased
15
Reduced
23
Closed

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$29.7M
2
KOS icon
Kosmos Energy
KOS
+$29.3M
3
BIIB icon
Biogen
BIIB
+$26.7M
4
SDRL icon
Seadrill
SDRL
+$25.2M
5
RPRX icon
Royalty Pharma
RPRX
+$22.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.73%
2 Financials 16.69%
3 Communication Services 14.9%
4 Healthcare 12.55%
5 Industrials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$3T
$134M 6.17%
609,896
-15,432
-2% -$3.16M
QXO
2
QXO Inc
QXO
$17.1B
$123M 5.67%
7,733,030
-8,817
-0.1% -$139K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.36T
$113M 5.2%
595,490
-246
-0% -$43K
C icon
4
Citigroup
C
$226B
$108M 5.01%
1,541,308
-550
-0% -$37.1K
ET icon
5
Energy Transfer Partners
ET
$70B
$99.7M 4.6%
5,091,882
-204,948
-4% -$3.63M
META icon
6
Meta Platforms (Facebook)
META
$1.52T
$86.4M 3.99%
147,628
-196
-0.1% -$115K
EXPE icon
7
Expedia Group
EXPE
$37.3B
$82.4M 3.8%
442,429
-204,900
-32% -$35.3M
NVDA icon
8
NVIDIA
NVDA
$5.43T
$81.7M 3.77%
608,563
-165
-0% -$22.7K
GM icon
9
General Motors
GM
$76.8B
$81.6M 3.76%
1,531,144
-18,930
-1% -$991K
RPRX icon
10
Royalty Pharma
RPRX
$25.3B
$73.3M 3.38%
2,875,089
+833,894
+41% +$22.1M
PPLI
11
People Inc
PPLI
$3.2B
$71.9M 3.32%
2,032,391
+4,543
+0.2% +$182K
UAL icon
12
United Airlines
UAL
$41.7B
$70.4M 3.25%
725,244
-280,313
-28% -$23.7M
OMF icon
13
OneMain Financial
OMF
$7.43B
$65.8M 3.04%
1,263,145
-150,070
-11% -$7.78M
SOFI icon
14
SoFi Technologies
SOFI
$23.5B
$65.5M 3.02%
4,251,680
-1,544,007
-27% -$20.1M
SDRL icon
15
Seadrill
SDRL
$2.73B
$65.3M 3.01%
1,676,777
+651,132
+63% +$25.2M
NCLH icon
16
Norwegian Cruise Line
NCLH
$8.83B
$63.9M 2.95%
2,483,809
-318,141
-11% -$8.04M
BIIB icon
17
Biogen
BIIB
$30.2B
$63.3M 2.92%
413,960
+158,018
+62% +$26.7M
UBS icon
18
UBS Group
UBS
$176B
$61.9M 2.86%
2,042,420
+20,401
+1% +$647K
KOS icon
19
Kosmos Energy
KOS
$1.52B
$58.6M 2.71%
17,147,729
+7,707,707
+82% +$29.3M
BABA icon
20
Alibaba
BABA
$307B
$58.5M 2.7%
689,712
+30,986
+5% +$2.93M
CVS icon
21
CVS Health
CVS
$122B
$58.3M 2.69%
1,298,429
+529,333
+69% +$29.7M
DAL icon
22
Delta Air Lines
DAL
$60.1B
$57.3M 2.64%
947,509
-316,065
-25% -$18.7M
ILMN icon
23
Illumina
ILMN
$29B
$54.8M 2.53%
409,955
-1,600
-0.4% -$228K
PLAY icon
24
Dave & Buster's
PLAY
$364M
$51.9M 2.39%
1,777,260
+476,662
+37% +$16.6M
COIN icon
25
Coinbase
COIN
$40.3B
$50.5M 2.33%
203,401
+26,569
+15% +$6.74M

Similar funds

Patient Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Patient Capital Management held 43 positions worth $2.17B, up 6.4% from $2.04B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.7%. Patient Capital Management opened 2 new positions and made no exits, leaving the 43-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.

  • Patient Capital Management's largest Q4 2024 buy was JD.com: 100,000 shares worth $3.47M.
  • Patient Capital Management added most to CVS Health in Q4 2024, an estimated $29.7M increase.
  • Patient Capital Management's biggest Q4 2024 reduction was Travel + Leisure Co, cutting an estimated $38.9M.
  • Patient Capital Management's ten largest holdings make up 45% of its $2.17B portfolio in Q4 2024.
  • Patient Capital Management opened 2 new positions and closed 0 in Q4 2024.
  • Patient Capital Management's portfolio value rose 6.4% quarter-over-quarter to $2.17B.

Based on Patient Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.